Overview

First Time in Human Study

Status:
Completed
Trial end date:
2010-04-07
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability, and pharmacokinetics of GSK356278 in male volunteers
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline